LifeBTK Trial: Drug-Eluting Resorbable Scaffold versus Angioplasty for Infrapopliteal Artery Disease
Release Date: 02/11/2025
SVS Meet the Secretary Candidates
Audible Bleeding
In this episode, Audible Bleeding Editors Sasank Kalipatnapu (), Falen Demsas sit down with Dr. Rabih Chaer (), Dr. Michael Conte(), Dr. Sherene Shalhub and Dr. Malachi Sheahan III, the four SVS secretary candidates for this year to learn more about them as part of the ongoing election process. Show links: —Home Page—provides a comprehensive overview of all the candidates. Their professional biographies and answers to questions about their plans for the future are available in both text and video formats. Show Guests: Dr. Rabih Chaer, Professor of Surgery and Chief of...
info_outline
SVS 2025 Meet the VP Candidates
Audible Bleeding
In this episode, Audible Bleeding Editors Sasank Kalipatnapu (), Richa Kalsi () sit down with Dr. Andres Schanzer and Dr. William Shutze, the two SVS vice presidential candidates for this year to learn more about them as part of the ongoing election process. Show links: provides a comprehensive overview of all the candidates. Their professional biographies and answers to questions about their plans for the future are available in both text and video formats. Show Guests: Dr. Andres Schanzer, Professor and Chief in the Division of Vascular and Endovascular Surgery, UMass...
info_outline
JVS Author Spotlight - Aridi, Motaganahalli, Nagarsheth, and Madabhushi
Audible Bleeding
Audible Bleeding editor Wen () is joined by 3rd year medical student Nishi (), 2nd year vascular fellow Donna, JVS editor Dr. Forbes ), and JVS-CIT editor Dr. Matt Smeds () to discuss some of our favorite articles in the JVS family of journals. This episode hosts Dr. Aridi, Dr. Motaganahalli, Dr. Nagarsheth, and Dr. Madabhushi, the authors of the following papers. Articles: Show Guests Dr. Hanaa Aridi ()- PGY3 at Indiana University School of Medicine Dr. Raghu L. Motaganahalli ()- Professor of Surgery at the Indiana University...
info_outline
The Improve AD Trial
Audible Bleeding
Dr. Ezra Schwartz (@ezraschwartz10) interviews Dr. Firas Mussa and Mr. Jake Howitt to discuss the IMPROVE-AD Trial, a landmark, multi-institutional study investigating treatment strategies for uncomplicated Type B Aortic Dissection (uTBAD). The IMPROVE-AD Trial is a multicenter randomized trial funded by the NIH/NHLBI that compares thoracic endovascular aortic repair (TEVAR) plus optimal medical therapy (OMT) vs. OMT and surveillance with selective TEVAR in patients with uncomplicated TBAD. The trial aims to address critical gaps in evidence left by prior studies (INSTEAD-XL, ADSORB), with a...
info_outline
JVS CIT Editorials and Abstracts - April 2025
Audible Bleeding
In this episode, we spotlight editorials and abstracts from the Journal of Vascular Surgery Cases, Innovations, and Techniques (). Editorials and Abstracts are read by Authors as well as members of the . Guests: Antonio L. Solano, MD (@solanotono) Hosts: John Culhane (@JohnCulhaneMD) Follow us Learn more about us at and provide us with your feedback with our .
info_outline
JVS Author Spotlight - Fereydooni and Satam
Audible Bleeding
Audible Bleeding editor Wen () is joined by first year vascular fellow Eva (), JVS editor Dr. Forbes ), to discuss some of our favorite articles in the JVS family of journals. This episode hosts Dr. Fereydooni and Dr. Satam, the authors of the following paper. Articles: Show Guests Dr. Arash Fereydooni: PGY5 integrated vascular resident at Stanford Dr. Keyuree Satam: PGY2 integrated vascular resident at Stanford Follow us Learn more about us at and provide us with your feedback with our .
info_outline
Fellowship Series - 6 Months In
Audible Bleeding
In this episode we catch up with first-year fellows Imani, Yasong, Wen, and Seth as they recap the first 6 months of training and the transition from general surgery to vascular surgery. They recount learning their way around new hospitals, navigating new cities, and settling into life as vascular surgeons. Follow us Learn more about us at and provide us with your feedback with our .
info_outline
JVS Author Spotlight - Gaffey, Hamouda, and Erben
Audible Bleeding
Audible Bleeding editor Wen () is joined by first year vascular fellow Eva (), second year vascular fellow Java (), JVS editor Dr. Forbes ), and JVS-VS associate editor Dr. Hedin to discuss some of our favorite articles in the JVS family of journals. This episode hosts Dr. Ann Gaffey, Dr. Mohammed Hamouda, and Dr. Young Erben, the authors of the following papers. Articles: Show Guests Dr. Ann Gaffey (): Assistant professor of surgery at UC San Diego School of Medicine in the Division of Vascular and Endovascular Surgery. Dr. Gaffey's clinical...
info_outline
JVS CIT Editorials and Abstracts - February 2025
Audible Bleeding
In this episode, we spotlight editorials and abstracts from the Journal of Vascular Surgery Cases, Innovations, and Techniques (). Editorials and Abstracts are read by Authors as well as members of the . Guests: Kelsey Schmittling, Medical Student (@kelseyum2plus) Hosts: John Culhane (@JohnCulhaneMD) Nishi Vootukuru (@Nishi_Vootukuru) Follow us Learn more about us at and provide us with your feedback with our .
info_outline
LifeBTK Trial: Drug-Eluting Resorbable Scaffold versus Angioplasty for Infrapopliteal Artery Disease
Audible Bleeding
In this episode of Audible Bleeding, Jamila, Anh, and Naveed discuss the LifeBTK Trial with Principal Investigator Dr. Brian DeRubertis, where we discuss the new Abbott Esprit everolimus-eluting resorbable scaffold for the below-knee popliteal space. Guest: Dr. DeRubertis, is the Principal Investigator of the LIFE-BTK trial. He is the Chief of the Division of Vascular & Endovascular Surgery at New York-Presbyterian and Weill Cornell Medicine in New York City. Audible Bleeding Team Dr. Jamila Hedhliis a general surgery resident at the University of Illinois. Anh Dang, (@QuynhAnh_Dang), is a...
info_outlineIn this episode of Audible Bleeding, Jamila, Anh, and Naveed discuss the LifeBTK Trial with Principal Investigator Dr. Brian DeRubertis, where we discuss the new Abbott Esprit everolimus-eluting resorbable scaffold for the below-knee popliteal space.
Guest:
Dr. DeRubertis, is the Principal Investigator of the LIFE-BTK trial. He is the Chief of the Division of Vascular & Endovascular Surgery at New York-Presbyterian and Weill Cornell Medicine in New York City.
Audible Bleeding Team
Dr. Jamila Hedhliis a general surgery resident at the University of Illinois.
Anh Dang, (@QuynhAnh_Dang), is a fourth year medical student at the University of Pennsylvania.
Dr. Naveed A. Rahman, (@naveedrahmanmd), is a Vascular Surgery Fellow at the University of Maryland.
References:
-
Drug-Eluting Resorbable Scaffold versus Angioplasty for Infrapopliteal Artery Disease (LIFE-BTK).
-
Advances in Endovascular Treatment of CLTI: Insights From the LIFE-BTK Trial.
-
The IN.PACT DEEP Clinical Drug-Coated Balloon Trial: 5-Year Outcomes.
Follow us @audiblebleeding
Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey.